CTCA Ranks First Among Major US Hospitals in 2017 Year-End Assessment of Consumer Sentiment

Corporate | January 30, 2018

Cancer Treatment Centers of America® (CTCA) today announced it ranked number one in YouGov’s 2017 BrandIndex assessment of consumer sentiment toward 42 major US hospitals and hospital systems for the third year in a row. The Buzz rankings, based on approximately 22,000 interviews with US adults between January and December 2017, placed CTCA® ahead of other highly regarded hospital systems including Mayo Clinic, John Hopkins Medicine, Cleveland Clinic and University of Texas MD Anderson Cancer Center.

“Cancer Treatment Centers of America has consistently ranked highly in consumer perceptions among all brands in recent years, which is a testament to how positively their efforts have resonated with individuals touched by cancer,” said YouGov BrandIndex CEO Ted Marzilli.

“This recognition reflects our resolute commitment to delivering the highest quality care for our patients,” said Peter Yesawich, Chief Growth Officer of CTCA. “It reaffirms our clinical teams’ dedication to helping patients fight their disease with the latest treatment options while focusing on their quality of life both during and after treatment.”

This is the third consecutive year CTCA is ranked first in YouGov’s BrandIndex Buzz Rankings, which asked consumers, “If you've heard anything about the brand in the last two weeks, through advertising, news or word of mouth, was it positive or negative?” to compile scores.

About YouGov BrandIndex

YouGov BrandIndex (brandindex.com) is the only daily consumer perception research service of brands, taking more than 4,800 interviews every day from a representative US population sample, and more than 1.5 million interviews per year. Respondents are drawn from an online panel of more than 1.8 MM US adults aged 18+.

About Cancer Treatment Centers of America
Cancer Treatment Centers of America® (CTCA) is a national oncology network of hospitals and outpatient care centers offering an integrated approach that combines surgery, radiation, chemotherapy, immunotherapy and advancements in precision medicine with supportive therapies to manage side effects and enhance quality of life during treatment and into survivorship. CTCA also offers qualified patients a range of clinical trials that may reveal new treatment options supported by scientific and investigational research. CTCA patient satisfaction scores consistently rank among the highest for all cancer care providers in the country. Visit cancercenter.com for more information.